China Opens Bidding in Seventh Bulk Procurement Round for Medical Consumables

China launched bidding for its seventh batch of national centralized volume-based procurement for medical consumables in Tianjin on September 10, according to state media reports. The tender covers 23 categories of digestive interventional consumables primarily utilized in endoscopic gastrointestinal procedures. A total of 156 domestic and international medical device manufacturers submitted bids across 558 products before the morning deadline, after which officials initiated public bid announcements. The round follows six previous national procurement drives spanning cardiology, orthopedics, ophthalmology, and other clinical specialties.

Endoscopic gastrointestinal procedures represent a high-volume clinical area with growing demand among China's aging population. By bringing 23 types of digestive intervention consumables into national volume-based procurement, healthcare authorities aim to curb out-of-pocket costs for patients and reduce expenditures from the national basic medical insurance fund. For medical device manufacturers, securing centralized volume quotas has become essential for maintaining hospital market access in China, even as tender price reductions compress operating margins across mature product lines.

China formally opened bidding for its seventh batch of national centralized volume-based procurement for medical consumables in Tianjin on September 10, state media outlets reported, expanding the country's price-negotiation mechanism into interventional gastroenterology. Enterprise representatives began submitting price quotation documents at 7:30 a.m. local time, with the submission window closing at 9:30 a.m., according to reports from Xinhua and People's Daily. Officials subsequently transitioned proceedings into the public bid-reading phase. In total, 156 medical device manufacturers submitted bids covering 558 separate products. The seventh centralized procurement round focuses specifically on 23 varieties of digestive interventional medical consumables. These devices are primarily deployed in endoscopic surgical procedures used to diagnose and treat gastrointestinal conditions, a sector that has seen rising clinical utilization across tertiary and secondary public hospitals. The current tender follows six earlier rounds of national bulk purchasing organized by Chinese medical insurance authorities. Those prior campaigns targeted major medical hardware and implants across multiple clinical specialties, including coronary stents, artificial hip and knee joints, orthopedic spine systems, sports medicine consumables, intraocular lenses, cochlear implants, peripheral vascular stents, drug-coated balloons, and urological interventional consumables. Through those previous procurement iterations, centralized purchasing has systematically covered core hospital departments such as cardiology, orthopedics, ophthalmology, vascular surgery, otolaryngology, urology, and gastroenterology. The initiative operates by aggregating procurement demand across public medical institutions nationwide, offering manufacturers guaranteed sales volume in exchange for significant unit price reductions. While official bidding materials have been logged and read on site, final winning enterprise rosters, tender price drops, and contracted supply allocations remain subject to official verification and formal publication by national healthcare security authorities following the completion of technical and commercial reviews.